We have found 803 companies that use Illumina DNA Sequencing. The companies using Illumina DNA Sequencing are most often found in United States and in the Higher Education industry. Illumina DNA Sequencing is most often used by companies with 1000-5000 employees and >1000M dollars in revenue. Our data for Illumina DNA Sequencing usage goes back as far as 1 years and 10 months.
|THE BROAD INSTITUTE, INC.||broadinstitute.org||United States||200M-1000M||1000-5000|
|Baylor College of Medicine||bcm.edu||United States||>1000M||5000-10000|
|GeneDx, Inc.||genedx.com||United States||10M-50M||200-500|
|Natera Inc||natera.com||United States||100M-200M||500-1000|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.3%. Other major and competing products in this category include:
For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.
Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (26%), Hospital & Health Care (21%), Biotechnology (10%) and Research (7%) are the largest segments.
|Industry||Number of companies|
|Hospital & Health Care||183|
|Staffing and Recruiting||15|
57% of Illumina DNA Sequencing customers are in United States and 6% are in United Kingdom.
|Country||Number of companies|
|Employees||Number of companies|
|Revenue (in USD)||Number of companies|